Webcast

Prescient Therapeutics Investor Briefing – 9 September

September 10, 2020

Prescient Therapeutics Investor Briefing – 9 September

Prescient Therapeutics (ASX: PTX) Webcast Replay

Steven Yatomi-Clarke, CEO & MD of Prescient Therapeutics (ASX:PTX) provides an update on the company’s next-gen CAR-T asset enhanced cell therapy capabilities – maybe the most promising global frontier in the fight against cancer – as well as their other cancer therapy programs.

Recorded on 9 September 2020 at 7pm (AEST)

Join the next Prescient Therapeutics webcast

Speak to our Advisor team about this company

FEATURE SPEAKERS

WARRICK LACE

Investor Relation Manager - Reach Markets

STEVEN YATOMI-CLARKE

Chief Executive Officer & Managing Director - Prescient Therapeutics

Speak to our Advisor team about this company



By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.